Skip to main content


Believing Is Doing (1.21.2022)

Dr. Jack Cush reviews the news and journal articles from this past week on These reports are about better outcomes in Lupus; Less Gout flares with T2T and the power of belief.

The Overpricing Of Drugs (1.14.2022)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.Live is March 19, 20th in Dallas, TX

Comorbidities in axSpA- A Focus on Cardiovascular Features Sponsored by Novartis Medical Affairs

Patients with axial spondyloarthritis (axSpA) commonly experience cardiovascular (CV) comorbidities. There is a need to holistically assess a patient, including considerations for managing disease activity and understanding the safety profile of available therapies as it relates to comorbidities.

2021 Rheumatology Year in Review (1.7.2022)

Dr. Jack Cush recants the top stories and changes for the field of rheumatology in 2021.

Best of 2021 -Jack of All Subspecialties (12.31.2021)

New to RheumNow? is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields.

My Podcast Gift (12.24.2021)

Merry Christmas and Happy Holidays from RheumNow. Dr. Jack Cush tells his podcast story - the genesis, keys to success and recommendations on how to get into podcasting - for teaching, practice, fun or influence.

Indications Awaiting (12.17.21)

Dr Jack Cush reviews the latest news, journal reports, regulatory approvals, plus 3 new cases from rheumatologists.

Women Leaders in Rheumatology

A moderated panel of prominent female rheumatologists will discuss the challenges and successes in clinical practice and research that they encountered during the COVID-19 pandemic.

Juvenile Psoriatic Arthritis and Enthesitis-Related Arthritis

There is a significant burden of disease associated with JPsA and ERA, with patients experiencing structural damage progression, risk of disability, and comorbidities that may persist into adulthood. This presentation led by Hermine Brunner, MD educates on the importance of early recognition and management.

T2T Debate - Prologue with Dr. Marty Bergman

Drs. Jack Cush and Martin Bergman gather to review the topic of treat-to-target (T2T) management in rheumatology. Both will debate the pro's and con's of the T2T strategy at the upcoming RWCS meeting on Feb. 17, 2022. You can register and learn more about the meeting at:

RheumNow Podcast - Telemedicine Upside (12.3.21)

Dr. Jack Cush discusses the evolution and future of telemedicine in rheumatology with the telemedicine guru - Dr. Alvin Wells

RheumNow Podcast - 60.40.20 Interview with Dr. Ed Keystone

Dr. Jack Cush interviews Professor Edward Keystone, MD (from the University of Toronto) on the origins and science behind the 60/40/20 benchmark and outcomes in rheumatoid arthritis.